# Analysis
- Adyen is spawning dozens of alumni founders. Here are the 10 fintechs you should knowAnalysis
June 20, 2023
Adyen is spawning dozens of alumni founders. Here are the 10 fintechs you should know
- Three startups on how to stand out in a competitive landscapeAnalysis
June 19, 2023
Three startups on how to stand out in a competitive landscape
- NDA guide for founders: What they are, how they work and red flags to avoidAnalysis
June 16, 2023
NDA guide for founders: What they are, how they work and red flags to avoid
- Could embedded finance help reverse the fintech slowdown?Analysis
June 13, 2023
Could embedded finance help reverse the fintech slowdown?
- UK investment falls off a cliff as government drags its heels on supportAnalysis
June 12, 2023
UK investment falls off a cliff as government drags its heels on support
- Liberty, equality, growth equity: Inside Macron’s plan to boost France’s tech IPOsAnalysis
June 12, 2023
Liberty, equality, growth equity: Inside Macron’s plan to boost France’s tech IPOs
- How Einstein's old stomping ground became Europe's spinout capitalAnalysis
June 12, 2023
How Einstein's old stomping ground became Europe's spinout capital
- Arrival founder sells shares as e-van maker hunts for a lifelineAnalysis
June 9, 2023
Arrival founder sells shares as e-van maker hunts for a lifeline
- May 2023’s seed rounds: Living longer, protecting children from the internet and saving wonky vegAnalysis
June 7, 2023
May 2023’s seed rounds: Living longer, protecting children from the internet and saving wonky veg
- Want to raise from VCs? You better get your management team in orderAnalysis
June 6, 2023
Want to raise from VCs? You better get your management team in order
- VC activity — and valuations — will pick up in next six months, survey saysAnalysis
June 6, 2023
VC activity — and valuations — will pick up in next six months, survey says
- 'Like doing your googling before dating': How to do investor due diligenceAnalysis
June 2, 2023
'Like doing your googling before dating': How to do investor due diligence
- Could these stem cell startups pave the way for the next miracle drug?Analysis
June 2, 2023
Could these stem cell startups pave the way for the next miracle drug?